Subscribe to
this category


A total of 20 posts are filed under Finance
InflaRx Raises $100 Million in IPO
German biopharmaceutical InflaRx, which is developing therapeutics for rare inflammatory diseases, completed a $100 million initial public… Continue Reading
Horama raises $22 million to Advance Gene Therapy Programs for Eye Disease
Rare Daily Staff French biotech Horama, which is developing gene therapies for the treatment of rare, inherited retinal diseases, said it… Continue Reading
Counsyl Raises $80 Million in Financing from Perceptive
Rare Daily Staff The genetic screening company Counsyl said it raised $80 million in a financing from Perceptive Advisors, a New York-based… Continue Reading
Perlara Completes $7.4 Million Funding Round
Rare Daily Staff Perlara, a drug discovery platform company focused on rare diseases, said it closed a $7.4 million equity round of… Continue Reading
New Investment Boosts Rare Disease Drug Accelerator
  Cydan, an orphan drug accelerator focused on developing therapies for rare genetic diseases, recently completed a $34 million financing… Continue Reading
Ablynx Raises $200 Million in Upsized IPO
Rare Daily Staff Belgium-based Ablynx, a late-stage biopharmaceutical developing Nanobodies, a new class of therapies that combine benefits… Continue Reading
Gemini Raises $42.5M to Develop Precision Therapeutics in Eye and Rare Genetic Diseases
Rare Daily Staff Gemini Therapeutics said it raised a $42.5 million series A venture round to fund its efforts to advance to the clinic new… Continue Reading